SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

COLOMBO, Gaia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.331
AS - Asia 6.246
EU - Europa 3.644
SA - Sud America 1.167
Continente sconosciuto - Info sul continente non disponibili 234
AF - Africa 148
OC - Oceania 33
Totale 22.803
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.054
SG - Singapore 2.330
CN - Cina 1.516
IT - Italia 956
BR - Brasile 913
VN - Vietnam 628
UA - Ucraina 563
HK - Hong Kong 511
DE - Germania 389
TR - Turchia 331
FR - Francia 320
GB - Regno Unito 303
PL - Polonia 236
BD - Bangladesh 218
FI - Finlandia 218
SE - Svezia 172
JP - Giappone 158
RU - Federazione Russa 153
IN - India 144
CA - Canada 120
MX - Messico 104
ID - Indonesia 90
AR - Argentina 87
NL - Olanda 65
ZA - Sudafrica 59
ES - Italia 54
IQ - Iraq 50
PK - Pakistan 42
EC - Ecuador 38
CO - Colombia 34
GR - Grecia 31
MY - Malesia 30
CL - Cile 28
DK - Danimarca 26
IR - Iran 25
VE - Venezuela 25
AU - Australia 24
AT - Austria 22
BE - Belgio 22
CH - Svizzera 21
SA - Arabia Saudita 19
TN - Tunisia 19
IL - Israele 17
MA - Marocco 17
PE - Perù 16
PH - Filippine 16
UZ - Uzbekistan 16
PY - Paraguay 15
EG - Egitto 14
PT - Portogallo 13
AE - Emirati Arabi Uniti 12
LT - Lituania 11
BY - Bielorussia 10
IE - Irlanda 10
KR - Corea 10
RO - Romania 10
JM - Giamaica 9
JO - Giordania 9
KE - Kenya 9
NZ - Nuova Zelanda 9
BO - Bolivia 8
CR - Costa Rica 8
CZ - Repubblica Ceca 8
BH - Bahrain 7
DZ - Algeria 7
TH - Thailandia 7
NP - Nepal 6
TW - Taiwan 6
AZ - Azerbaigian 5
BG - Bulgaria 5
GT - Guatemala 5
HU - Ungheria 5
KZ - Kazakistan 5
LB - Libano 5
PA - Panama 5
PS - Palestinian Territory 5
GE - Georgia 4
KW - Kuwait 4
LV - Lettonia 4
NI - Nicaragua 4
AL - Albania 3
BB - Barbados 3
HN - Honduras 3
HR - Croazia 3
KG - Kirghizistan 3
ML - Mali 3
NG - Nigeria 3
OM - Oman 3
PR - Porto Rico 3
SY - Repubblica araba siriana 3
TT - Trinidad e Tobago 3
AM - Armenia 2
BA - Bosnia-Erzegovina 2
BS - Bahamas 2
ET - Etiopia 2
EU - Europa 2
GA - Gabon 2
GD - Grenada 2
KH - Cambogia 2
LY - Libia 2
Totale 22.535
Salva come PNG Salva come JPEG
Città #
Singapore 1.460
Ashburn 1.077
Fairfield 998
Woodbridge 957
Houston 702
Jacksonville 624
Santa Clara 616
San Jose 555
Chandler 545
Hong Kong 484
Ann Arbor 472
Beijing 424
Council Bluffs 380
Wilmington 372
Seattle 369
Cambridge 328
Izmir 243
Warsaw 224
Ho Chi Minh City 199
Nanjing 182
Princeton 153
Hanoi 147
Tokyo 145
Los Angeles 135
Lauterbourg 117
New York 111
Dallas 109
Boardman 100
Ferrara 100
Helsinki 94
San Diego 78
Milan 74
Shenyang 68
São Paulo 64
Mexico City 56
Rome 55
Nanchang 53
Shanghai 45
Hebei 44
Jakarta 44
Tianjin 44
London 42
Chicago 40
Atlanta 37
Haiphong 35
Mountain View 34
Redwood City 33
Da Nang 32
Rio de Janeiro 32
Hefei 31
Moscow 31
Bologna 30
Brooklyn 29
Denver 29
San Francisco 29
Toronto 29
Falls Church 28
Frankfurt am Main 28
Jiaxing 28
Munich 28
Bremen 26
Addison 25
Baghdad 23
Copenhagen 23
Orem 23
Buffalo 22
Johannesburg 22
Columbus 21
Phoenix 21
Poplar 21
Changsha 20
The Dalles 20
Brussels 19
Parma 19
Brasília 18
Naples 18
Philadelphia 18
Zhengzhou 18
Boston 16
Falkenstein 16
Jinan 16
Nuremberg 16
Santiago 16
Tashkent 16
Belo Horizonte 15
Norwalk 15
Montreal 14
Orange 14
Des Moines 13
Guangzhou 13
Guayaquil 13
Manchester 13
Mumbai 13
Stockholm 13
Amsterdam 12
Auburn Hills 12
Fortaleza 12
Hangzhou 12
Hải Dương 12
Kuala Lumpur 12
Totale 14.333
Salva come PNG Salva come JPEG
Nome #
Studio di uno spray topico di sucralfato gel e cidofovir per la terapia antivirale di ovini 406
Opportunity and challenges of nasal powders: Drug formulation and delivery 402
PRINCIPI DI CALCOLO FARMACEUTICO 400
In vivo nose-to-brain delivery of the hydrophilic antiviral ribavirin by microparticle agglomerates 329
Biological In Vitro Models for Absorption by Nonoral Routes 291
Chimerical agglomerates of lecithin/chitosan nanoparticles for powder nasal delivery 283
The development of a single-use, capsule-free multi-breath tobramycin dry powder inhaler for the treatment of cystic fibrosis 265
Effect of residual water content on the physico-chemical properties of sucralfate dried gel obtained by microwave drying 249
Dry powder inhalers: An overview of the in vitro dissolution methodologies and their correlation with the biopharmaceutical aspects of the drug products 243
Bioadhesive sucralfate gel-based suspension containing cidofovir for spray treatment of viral infections in lamb and sheep 241
Diclofenamic acid-vitamin C conjugates: stability and interaction studies with ascorbate transporters 234
Surface-modified nanocarriers for nose-to-brain delivery: From bioadhesion to targeting 229
Design of experiments (DoE) in pharmaceutical development 228
Respiratory Drug Delivery 226
Assemblage of Novel Release Modules for the Development of Adaptable Drug Delivery Systems 217
Combinations of colistin solutions and nebulisers for lung infection management in cystic fibrosis patients 215
Ex vivo permeation of tamoxifen and its 4-OH metabolite through rat intestine from lecithin/chitosan nanoparticles 215
Bioadhesive film for transdermal delivery of lidocaine: in vitro and in vivo behavior 213
Brain Targeting of an Antiischemic Agent by Nasal Administration of Microparticles 211
Nasal powders of thalidomide for local treatment of nose bleeding in persons affected by hereditary hemorrhagic telangiectasia 209
Spray-dried amikacin sulphate powder for inhalation in cystic fibrosis patients: The role of ethanol in particle formation 203
Anti-inflammatory flurbiprofen nasal powders for nose-to-brain delivery in Alzheimer’s disease 196
Chitosan coated human serum albumin nanoparticles: A promising strategy for nose-to-brain drug delivery 194
Artesunate-clindamycin multi-kinetics and site-specific oral delivery system for antimalaric combination products 192
Swellable and Rigid Matrices: Controlled Release Matrices with Cellulose Ethers 190
Dry powder inhalers of gentamicin and leucine: formulation parameters, aerosol performance and in vitro toxicity on CuFi1 cells 187
The use of fatty acids as absorption enhancer for pulmonary drug delivery 187
Floating modular drug delivery systems with buoyancy independent of release mechanisms to sustain amoxicillin and clarithromycin intra-gastric concentrations 187
Bioencapsulation methods for cell inclusion in polysaccharidic matrices for clinical applications 183
Alginate and cell combination product for wound healing 182
The Effect of Residual Water on Antacid Properties of Sucralfate Gel Dried by Microwaves 180
Prolonged duration local anesthesia from tetrodotoxin-enhanced local anesthetic microspheres 180
N6-cyclopentyladenosine : selective brain targeting by nasal administration of microparticles 177
Autoassembled nanoparticles of lecithin/chitosan for oral delivery of the anticancer drug tamoxifen citrate 176
Skin permeation of 5-methoxypsoralen from topical dosage forms 175
Combination of alginate and cells for skin regeneration 173
Flurbiprofen sodium microparticles and soft pellets for nose-to-brain delivery: Serum and brain levels in rats after nasal insufflation 168
Module assemblage technology for floating systems: in vitro flotation and in vivo gastro-retention 167
Prolonged duration local anesthesia with lipid-protein-sugar particles containing bupivacaine and dexamethasone 167
Therapeutic paint of cidofovir/sucralfate gel combination topically administered by spraying for treatment of orf virus infections 166
A Study for the Development of Mesalazine Multiparticulate Dosage Forms for Colon Delivery in Pediatric Patients 166
Ex vivo propofol permeation across nasal mucosa: A proof-of-concept study for outpatient light sedation via nasal route 165
Soft Agglomerates of Pantoprazole Gastro-resistant Microparticles for Oral Administration and Intestinal Release 164
A new 5-methoxypsoralen formulation for the topical treatment of psoriasis 163
The suitability of disintegrating force kinetics for studying the effect of manufacturing parameters on spironolactone tablet properties 163
A Clinical Study of a Methacholine Dry Powder for the Bronchial Challenge Test 162
The formulation of a novel macrolide solution pressurised metered dose inhaler: the use of Clarithromycin as an anti-inflammatory for bronchiectasis therapy 162
Novel Platforms for Oral Drug Delivery 162
Nasal administration and brain targeting of an antiischemic agent 161
From tablets to pharmaceutical nanotechnologies: Innovation in drug delivery strategies for the administration of antimalarial drugs 157
Prolonged duration local anesthesia with lipid-protein-sugar particles containing bupivacaine and dexamethasone 156
In vitro and in vivo study of 5-methoxypsoralen skin concentration after topical application 154
Esomeprazole immediate release tablets: Gastric mucosa ex vivo permeation, absorption and antisecretory activity in conscious rats 154
Formulation Strategies for Antitubercular Drugs by Inhalation 153
Prolongation of sciatic nerve blockade by in situ cross-linked hyaluronic acid 152
Post-iontophoresis transport of ibuprofen lysine across rabbit ear skin 152
Brain distribution of ribavirin after intranasal administration 152
Aerosolization performance of jet nebulizers and biopharmaceutical aspects 151
Methacholine dry powder inhaler as a new tool for bronchial challenge test 150
Preparation and Biophysical Characterization of Quercetin Inclusion Complexes with β-Cyclodextrin Derivatives to be Formulated as Possible Nose-to-Brain Quercetin Delivery Systems 148
null 147
Efficacy and biocompatibility of bupivacaine-loaded lipid-protein-sugar particles for prolonged duration local anesthesia 146
Mechanisms of formation and disintegration of alginate beads obtained by prilling 146
Single layer dermal patch: skin accumulation assessed by tape stripping 144
Effect of excipient composition on the biocompatibility of bupivacaine-containing microparticles at the sciatic nerve 142
Geometric Release Systems: Principles, Release Mechanisms, Kinetics, Polymer Science, and Release-Modifying Material 141
Nasal powders of quercetin-β-cyclodextrin derivatives complexes with mannitol/lecithin microparticles for Nose-to-Brain delivery: In vitro and ex vivo evaluation 139
Aerodynamic assessment for inhalation products: fundamentals and current pharmacopoeial methods 138
In vitro and in vivo study of a desmopressin nasal powder 137
Brain Uptake of an Antiischemic Agent by Nasal Administration of Microparticles 137
Rheological, thermal and spectroscopical properties of the macromolecular complex between sodium hyaluronate and cisplatin for anticancer chemotherapy 136
Advanced Dome cellulose/alginate/chitosan composite matrix design with gastric and intestinal co-targeting capacities 135
Chitosan-coated nanoparticles: Effect of chitosan molecular weight on nasal transmucosal delivery 135
Compositions in powder form made of soft agglomerates of a micronized drug and of a two-components excipient, and process for their preparation 134
PRODRUGS, MICRO OR NANOPARTICULATE SYSTEMS AND NASAL ADMNISTRATION AS NON INVASIVE APPROACHES AGAINST BRAIN DISEASES AND AIRBORNE INFECTIONS. LOCO-REGIONAL THERAPY OF CANCER 133
The role of dissolution test in a comparison of generic and branded controlled-release products 132
Comparative Serum and Brain Pharmacokinetics of Quercetin after Oral and Nasal Administration to Rats as Lyophilized Complexes with β-Cyclodextrin Derivatives and Their Blends with Mannitol/Lecithin Microparticles 131
Antidiuretic effect of desmopressin chimera agglomerates by nasal administration in rats 130
Strategies in bupivacaine delivery for prolonged duration local anesthesia 129
Dry powder inhaler of colistimethate sodium for lung infections in cystic fibrosis: optimization of powder construction 129
Therapeutic paint for simultaneous delivery of sucralfate gel and cidofovir in the treatment of veterinary viral skin infections 126
Nasal powders of morphine microcrystals agglomerates 126
Spray therapeutic paint for topical treatment of orf virus skin infections in breeding sheep 125
Film for active ingredients dermal and transdermal administration 124
In vitro comparison of four anti-inflammatory topical medications 123
Nose-to-brain delivery of ribavirin (RBV) for the treatment of viral encephalitis 123
Soft agglomerates containing microencapsulated levothyroxine for buccal or oral delivery 123
null 122
Development of artemisinin - β-cyclodextrin complex agglomerates 122
In vitro permeation of desmopressin across rabbit nasal mucosa from liquid nasal sprays: The enhancing effect of potassium sorbate 122
In vitro transport studies across excised nasal mucosa for three drug candidates to nose-to-brain delivery 121
Orphan Designation and Cisplatin/Hyaluronan Complex in an Intracavitary Film for Malignant Mesothelioma 120
Soft chimera agglomerates for desmopressin nasal administration: an in vitro and in vivo study 119
Development of a spray-dried powder for nasal administration of desmopressin acetate 117
New modules, new assemblage kits and new assemblies for the controlled release of substances 117
Enhancing ribavirin nose-to-brain delivery by powder formulation for veterinary CNS infections 117
Multi-kinetics and site-specific release of gabapentin and flurbiprofen from oral fixed-dose combination: in vitro release and in vivo food effect 117
Drug binding to human serum heme-albumin impairs allosterically peroxynitrite detoxification 116
Assemblage of drug release modules: effect of module shape and position in the assembled systems on floating behavior and release rate 115
Progesterone-loaded lecithin/chitosan isopropylmyristate nanoparticles for transmucosal delivery 114
Totale 17.233
Salva come PNG Salva come JPEG
Categoria #
all - tutte 97.196
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 4.944
Totale 102.140
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.060 0 0 98 66 55 76 44 76 41 101 118 385
2022/20231.299 164 54 27 159 238 193 34 127 167 15 86 35
2023/2024608 93 91 34 23 41 25 15 28 9 28 55 166
2024/20252.881 93 46 229 87 433 317 173 165 445 344 301 248
2025/20267.856 561 435 730 1.059 939 488 731 561 753 936 393 270
2026/20271.111 416 455 240 0 0 0 0 0 0 0 0 0
Totale 22.803